Legal & General Group PLC Co Diagnostics, Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$7.16 - $9.56 $29,005 - $38,727	-4,051 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.52 - $19.21 $1,584 - $3,573	-186 Reduced 4.39%	4,051 $39,000
Q3 2020 Nov 13, 2020	SELL	$8.24 - $30.8 $9,096 - $34,003	-1,104 Reduced 20.67%	4,237 $57,000
Q2 2020 Aug 14, 2020	BUY	$7.46 - $23.42 $39,843 - $125,086	5,341 New	5,341 $103,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $26.3M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.